1. Home
  2. DYAI

DYAI

Dyadic International Inc.

Logo Dyadic International Inc.

Health Care

Biotechnology: Biological Products (No Diagnostic Substances)

Nasdaq

as 04-15-2024 3:32pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Dyadic International Inc is a world-wide biotechnology platform company. The company has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins, and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.

Founded: 1979 Country:
United States
United States
Employees: N/A City: JUPITER
Market Cap: 52.4M IPO Year: 2004
Target Price: $6.00 AVG Volume (30 days): 24.0K
Analyst Decision: Strong Buy Number of Analysts: 1
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -0.24 EPS Growth: N/A
52 Week Low/High: $1.19 - $2.40 Next Earning Date: 05-08-2024
Revenue: $2,898,806 Revenue Growth: -1.07%
Revenue Growth (this year): 51.3% Revenue Growth (next year): 41.86%

Share on Social Networks: